Race Oncology Ltd. (AU:RAC)
ASX:RAC
Australian Market
Holding AU:RAC?
Track your performance easily

Race Oncology Ltd. (RAC) Share Price & Analysis

14 Followers

RAC Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.28%99.72%
― Other Institutional Investors
99.72% Public Companies and
Individual Investors

RAC FAQ

What was Race Oncology Ltd.’s price range in the past 12 months?
Race Oncology Ltd. lowest share price was AU$0.64 and its highest was AU$2.09 in the past 12 months.
    What is Race Oncology Ltd.’s market cap?
    Currently, no data Available
    When is Race Oncology Ltd.’s upcoming earnings report date?
    Race Oncology Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 106 days.
      How were Race Oncology Ltd.’s earnings last quarter?
      Race Oncology Ltd. released its earnings results on Aug 27, 2024. The company reported -AU$0.049 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.049.
        Is Race Oncology Ltd. overvalued?
        According to Wall Street analysts Race Oncology Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Race Oncology Ltd. pay dividends?
          Race Oncology Ltd. does not currently pay dividends.
          What is Race Oncology Ltd.’s EPS estimate?
          Race Oncology Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Race Oncology Ltd. have?
          Race Oncology Ltd. has 170,472,720 shares outstanding.
            What happened to Race Oncology Ltd.’s price movement after its last earnings report?
            Race Oncology Ltd. reported an EPS of -AU$0.049 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.514%.
              Which hedge fund is a major shareholder of Race Oncology Ltd.?
              Currently, no hedge funds are holding shares in AU:RAC
              ---

              Race Oncology Ltd. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              78.68%
              12-Months-Change

              Fundamentals

              Return on Equity
              -63.10%
              Trailing 12-Months
              Asset Growth
              -24.06%
              Trailing 12-Months

              Company Description

              Race Oncology Ltd.

              Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              LBT Innovations Limited
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis